Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells

por Bridges, Kathleen A., Toniatti, Carlo, Buser, Carolyn A., Liu, Huifeng, Buchholz, Thomas A., Meyn, Raymond E.
Publicado 2014

MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells

por Bridges, Kathleen A., Chen, Xingxing, Liu, Huifeng, Rock, Crosby, Buchholz, Thomas A., Shumway, Stuart D., Skinner, Heath D., Meyn, Raymond E.
Publicado 2016

p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade

por Molkentine, David P., Molkentine, Jessica M., Bridges, Kathleen A., Valdecanas, David R., Dhawan, Annika, Bahri, Reshub, Hefner, Andrew J., Kumar, Manish, Yang, Liangpeng, Abdelhakiem, Mohamed, Pifer, Phillip M., Sandulache, Vlad, Sheth, Aakash, Beadle, Beth M., Thames, Howard D., Mason, Kathryn A., Pickering, Curtis R., Meyn, Raymond E., Skinner, Heath D.
Publicado 2022